Results 181 to 190 of about 34,871 (236)

RadioPharm: the database of radiopharmaceuticals. [PDF]

Nucleic Acids Res
Liu J, Liu X, Zhang Y, Li X, Sun Y, Li T, Wei L, Mou M, Yang H, Yuan P, Li X, Zhang Z, Jia Y, Fu Y, Zhang Y, Zhang Y, Jia Q, Zhu F.   +17 more
europepmc   +1 more source

Preliminary biological evaluation of a [¹⁷⁷Lu]Lu-labeled peptide targeting Nectin-4. [PDF]

EJNMMI Radiopharm Chem
Li D, Zhang Y, Mu C, Cao X, Chen M, Li X, Chen W, Li Z.   +7 more
europepmc   +1 more source

Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals [PDF]

Nuclear Medicine Communications, 2021
Radiopharmaceuticals are radioactive compounds used in nuclear medicine, consisting of a radioactive moiety and a pharmaceutical part. Radiopharmaceuticals are used for diagnosis (predominantly) and therapy (to a lesser extent). Adverse drug reactions are undesirable, unexpected, often harmful drug responses that occur when the drug is administered in ...
Humeyra, Battal, Asuman Yekta, Ozer
openaire   +3 more sources

SPECT Radiopharmaceuticals for Dementia [PDF]

Current Radiopharmaceuticals, 2014
Over the last decade the interest towards functional neuroimaging has gradually increased, especially in the field of neurodegenerative diseases. At present, diagnosis of dementia is mostly clinical. Numerous modalities of neuroimaging are today available, each of them allowing a different aspect of neurodegeneration to be investigated. Although during
Guidotti, Claudio, FARIOLI, DANIELA, Gaeta, Maria Chiara, Giovannini, Elisabetta, Lazzeri, Patrizia, Meniconi, Martina, Ciarmiello, Andrea   +6 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Pitfalls With Radiopharmaceuticals

American Journal of the Medical Sciences, 2011
There is a considerable body of evidence describing that the pharmacokinetics and pharmacodynamics of radiopharmaceuticals may be changed by a variety of drugs, disease states and in some cases, surgical procedures.: To systematically search the medical literature and review the published evidence on adverse reactions to radiopharmaceuticals.MEDLINE ...
Ralph Santos-Oliveira, Marcio Machado
exaly   +3 more sources

Therapeutic Radiopharmaceuticals

Chemical Reviews, 1999
Timothy J Hoffman, Wynn A Volkert, T J Hoffman   +2 more
exaly   +3 more sources

Stability of 11C-labeled PET radiopharmaceuticals [PDF]

Applied Radiation and Isotopes, 2004
The stability of widely used 11C-radiopharmaceuticals was investigated. The purity of many 11C-radiopharmaceuticals was found to be low even at the end of synthesis and to lower with time by radiolysis.
478497, 山口 政俊, 478496, 福村 利光, 478499, 478498, Suzuki, Kazutoshi, 478495, Yamaguchi, Masatoshi, Nakao, Ryuji, 鈴木 和年, 中尾 隆士, Fukumura, Toshimitsu, 478501, 478500, 478502   +15 more
exaly   +1 more source

“Naked” radiopharmaceuticals

International Journal of Radiation Oncology*Biology*Physics, 2006
The term "naked" radiopharmaceuticals, more appropriately, "unbound" radiopharmaceuticals, refers to any radioisotope used for clinical research or clinical purposes that is not attached to a chemical or biological carrier, and that localizes in various tissues because of a physiologic or chemical propensity/affinity, or secondary to focal anatomic ...
openaire   +2 more sources

RADIOPHARMACEUTICALS

2023
Radiopharmaceuticals (RPs) have revolutionized the fields of nuclear medicine, diagnostic imaging, and targeted therapy. The chapter begins by elucidating the brief explanation of production and design of RPs. This chapter focuses on newly produced diagnostic & therapeutic radiopharmaceuticals that are being employed in normal clinical settings as ...
Vipasha Sharma, Suman Khurana, Mukesh Rani, Arun Mittal, Parveen Kumar Goyal   +4 more
openaire   +1 more source